AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hannover Rueck SE

Earnings Release Nov 8, 2017

197_ip_2017-11-08_0df386b2-285e-4243-8d26-143722ab8923.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Conference Call on Interim Report 3/2017

Hannover, 8 November 2017

Q3 losses absorbed within quarterly earnings Positive Q3 result supported by sale of listed equities

Group
Gross written premium:
EUR 13,484 m. (+8.3%) Attractive GWP growth (f/x adjusted +9.5%)
Net premium earned:
EUR 11,541 m. (+7.2%) NPE f/x-adjusted growth of +8.4%
EBIT:

Group net income:
EUR 806 m.
EUR 549 m.
EBIT and net income impacted by high frequency/
severity of major losses but aided by a strong
RoE:

BVPS:
8.5%
EUR 68.00
investment result
RoE
only slightly below our minimum target

BVPS decreased by –8.9% due to capital

management measures and renewed Euro
strengthening
Property & Casualty R/I Life & Health R/I Investments
EBIT:
Net major losses of EUR 894 m.

(13.2% of NPE) exceed budget
C/R slightly inflated mainly due to

higher share of Structured R/I
Accelerated GWP growth (f/x

adjusted +16.1%) driven by new
business in Structured R/I
EUR 602 m. EBIT:

claims from legacy US mortality

EUR 45m. as expected
Strong earnings growth from

Financial solutions business
EUR 206 m.
Continuously higher than expected
One-off impact from US recapture of
GWP growth (f/x adjusted +0.7%) in
line with expectations
NII:
RoI
from AuM:
RoI

target (>2.7%)

of listed equities (EUR 226 m.)
Strengthening of EUR leads to

decrease in AUM (-3.8%)
EUR 1.383 m.
3.9%
significantly exceeds full-year
Increased realised gains due to sale

Strong investment income ...

... partly mitigates significant impact from natural catastrophes

Group figures in m. EUR Q3/2016 Q3/2017 Δ Q1-3/2016 Q1-3/2017 Δ
Gross written premium 4,170 4,486 7.6% 12,454 13,484 8.3%
Net premium earned 3,600 4,018 11.6% 10,767 11,541 7.2%
Net underwriting result 47 (590) - 44 (669) -
- Incl. funds withheld 121 (533) - 294 (488) -
Net investment income 402 603 50.2% 1,146 1,383 20.6%
- From assets under own mgmt. 327 546 66.9% 897 1,202 34.1%
- From funds withheld 74 57 -23,6% 250 180 -27.9%
Other income and expenses (5) (6) 32.3% 0 92 -
Operating profit/loss (EBIT) 444 7 -98.4% 1,191 806 -32.3%
Interest on hybrid capital (18) (18) 0.3% (54) (54) -0.0%
Net income before taxes 426 (11) - 1,137 753 -33.8%
Taxes (112) 47 - (307) (143) -53.4%
Net income 314 36 -88.6% 830 610 -26.6%
- Non-controlling interests 10 22 117.5% 38 61 58.0%
Group net income 304 14 -95.4% 792 549 -30.7%
Retention 89.4% 89.7% 89.6% 90.1%
EBIT margin (EBIT/Net premium earned) 12.3% 0.2% 11.1% 7.0%
Tax ratio 26.3% - 27.0% 19.0%
Earnings per share (in EUR) 2.52 0.11 6.57 4.55

Continued positive operating cash flow AuM -3.8% driven by strengthening of the Euro and dividend payment

Shareholders' equity continues to be strong Drivers: Q3 result, dividend payment and negative effects from currency translation

EBIT margin of 8.9% despite nat cat frequency Moderate underwriting loss, mitigated by favourable Invesment Income

Property & Casualty R/I in m. EUR Q3/2016 Q3/2017 Q1-3/2016 Q1-3/2017 YTD
Gross written premium 2,493 2,772 7,121 8,199 GWP f/x adjusted +16.1%, mainly from Structured

R/I; diversified growth in other areas
Net premium earned 2,087 2,440 5,925 6,753 NPE f/x adjusted +14.9%
Net underwriting result
incl. funds withheld
116 (446) 294 (296) Major losses of EUR 894 m. (13.2% of NPE)

exceeded the budget by EUR 271 m. (4.0%p)
Combined ratio
incl. interest on funds withheld
94.4% 118.3% 95.0% 104.4% No changes to Ogden reserving ( EUR 291 m.

compensated by IBNR reserves). Reserve
redundancies unchanged at Q2 level
Net investment income from assets
under own management
219 460 624 933 NII positively influenced by realisation of valuation

reserves in equities of EUR 226 m.
Other income and expenses (3) (46) (23) (36) Other income and expenses mainly impacted by

negative f/x effects
Operating profit/loss (EBIT) 332 (33) 895 602 EBIT margin of 8.9% (Q1-3/2016: 15.1%) below

target of 10%
Tax ratio 25.8% 180.6% 27.3% 16.1% Low tax ratio due to tax-reduced gains from

disposal of listed equities
Group net income 237 5 615 449
Earnings per share (in EUR) 1.97 0.04 5.10 3.72

Major losses at a comparable level to 2005 & 2011 Still high uncertainty in 2017 for nat cat losses

Natural and man-made catastrophe losses* in m. EUR

* Up to 2011 claims over EUR 5 m. gross, from 2012 onwards claims over EUR 10 m. gross

Hannover Re estimates loss for 3 major hurricanes at EUR 650m Solid retrocession capacity still available for the remainder of the year

Catastrophe losses* in m. EUR Date Gross Net
Storm / Tornados, USA 18 - 21 Jan 12.3 9.2
Wildfires, Chile 21 Jan - 3 Feb 18.9 16.0
Cyclone "Debbie", Australia 27 - 28 Mar 59.4 42.2
Wildfires, South Africa 7 Jun 17.7 15.0
Typhoon "Hato", China 22 - 23 Aug 27.1 13.4
Hurricane "Harvey" 23 - 31 Aug 229.7 100.0
Hurricane "Irma" 5 - 13 Sep 787.4 329.9
Earthquake, Mexico 7 - 8 Sep 22.3 21.5
Hurricane "Maria" 18 - 21 Sep 315.6 220.8
Earthquake, Mexico 19 Sep 50.7 50.0
10 Natural catastrophes 1,541.1 818.0
1 Property claim 56.9 48.6
2 Credit claims 27.6 27.6
13 Major losses 1,625.6 894.3

* Natural catastrophes and other major losses in excess of EUR 10 m. gross

High nat cat losses drive C/R above MTCR

margin Q1-3/2017: Combined Ratio vs. MtCR 115.4% 92.3% 94.3% 93.0% 90.4% 145.6% 95.8% 98.4% 155.2% 100.0% 104.4% 0% 20% 40% 60% 80% 100% 120% North America* Continental Europe* Marine Aviation Credit, surety and political risks UK, Ireland, London market and direct Facultative R/I Worldwide Treaty* R/I Cat XL Structured R/I and ILS Target markets Specialty lines worldwide Global R/I Total 8.5% 22.8% 25.3% 26.1% 20.4% -24.3% 16.9% 12.0% -35.2% 2.3% 8.9%

Combined Ratio MtCR = Maximum tolerable Combined Ratio

* All lines of Property & Casualty reinsurance except those stated separately

EBIT

Profitability in L&H negatively impacted by US mortality

Life & Health R/I in m. EUR Q3/2016 Q3/2017 Q1-3/2016 Q1-3/2017 YTD
Gross written premium 1,677 1,714 5,333 5,284 GWP f/x adjusted +0.7%, reduced premium volume

from large-volume treaties offset by diversified
Net premium earned 1,513 1,578 4,841 4,788 growth in other areas
NPE f/x adjusted growth +0.3%
Net underwriting result
incl. funds withheld
5 (86) 1 (193) Technical result impacted by legacy US mortality

business as well as recapture in Q3/2017
Net investment income from assets
under own management
105 86 263 266 Favourable investment income

Increased other income and expenses due to strong
Other income and expenses 0 41 26 133 contribution from deposit accounted treaties (Q1-
3/2017: EUR 139 m.)
Operating profit/loss (EBIT) 111 41 290 206 EBIT margins:


Financial solutions: 27.4%
EBIT margin 7.4% 2.6% 6.0% 4.3%
Longevity: 1.9%

Mortality and Morbidity: 0.3%
Tax ratio 28.8% 45.9% 26.9% 31.9%
Group net income 78 22 209 136
Earnings per share (in EUR) 0.65 0.18 1.73 1.13

Realisations from listed equity boost strong result even further Ordinary investment income increased by 11.5%

in m. EUR Q3/2016 Q3/2017 Q1-3/2016 Q1-3/2017 RoI
Ordinary investment income* 285 312 855 953 3.1%
Realised gains/losses 74 260 154 343 1.1%
Impairments/appreciations &
depreciations
(13) (11) (61) (34) -0.1%
Change in fair value of financial
instruments (through P&L)
9 12 29 22 0.1%
Investment expenses (27) (26) (80) (82) -0.3%
NII from assets under own mgmt. 327 546 897 1,202 3.9%
NII from funds withheld 74 57 250 180
Total net investment income 402 603 1,146 1.383
Unrealised gains/losses of investments 31 Dec 16 30 Sep 17
31 Dec 16 30 Sep 17
On Balance-sheet 1,355 1,179
thereof Fixed income AFS 728 717
Off Balance-sheet 509 447
thereof Fixed income HTM, L&R 370 307
Total 1,864 1,627

YTD

  • Strong rise in ordinary income despite lower yielding fixed income portfolio mainly due to high partially extraordinary - income from private equity and real estate funds; (absolute) income from FIS higher than last year´s
  • Realised gains/losses impacted by liquidation of listed equity. Gain from equity sale represents EUR 226 m. or 0.7 %-p.
  • Decrease in impairments mostly attributable to listed and private equity
  • Lower valuation reserves mostly due to listed equity; higher EURyields reduce reserves of (semi-) government bonds

* Incl. results from associated companies

Ordinary income supported by less liquid asset classes Real estate and PE boost ordinary income yield clearly beyond target to 3.1%

Asset allocation

Investment category 30 Sep 17
Fixed-income securities 88 %
- Governments 31 %
- Semi-governments 17 %
- Corporates 32 %
Investment grade 27 %
Non-investment grade 5 %
- Pfandbriefe, Covered Bonds, ABS 8 %
Equities 2 %
- Listed Equity < 1%
- Private Equity 2 %
Real estate/real estate funds 5 %
Others 1 %
Short-term investments & cash 5 %
Total market values in bn. EUR 40.6

Economic view based on market values as at 30 September 2017 * Before real estate-specific costs

Target Matrix 2017 Profit targets influenced by extraordinary high nat cat frequency

Business group Key figures Strategic targets
for 2017
Q1-3/2017
Group Return on investment1) >2.7% 3.9%
Return on equity2) ≥9.7% 8.5%
Earnings per share growth (y-o-y) ≥6.5% -30.7%
Value creation per share3) ≥7.5% n.a.
Property & Casualty R/I Gross premium growth 3% - 5% 16.1%
Combined ratio ≤96% 104.4%
EBIT margin6) ≥10% 8.9%
xRoCA7) ≥2% n.a.
Life & Health R/I Gross premium growth 5% - 7% 0.7%
Value of New Business (VNB)9) ≥ EUR 220 m. n.a.
EBIT margin6) Financial solutions/Longevity ≥2% 14.1%
EBIT margin6) Mortality/Morbidity ≥6% 0.3%
xRoCA7) ≥3% n.a.
1) Excl. effects from ModCo
derivatives
2) After tax; target: 900 bps above 5-year average return of 10-year German government bonds

5) Incl. expected net major losses of EUR 825 m. 6) EBIT/net premium earned

9) Based on a cost of capital of 6% (until 2014: 4.5%)

3) Growth in book value per share + paid dividend 4) On average throughout the R/I cycle; at unchanged f/x rates

7) Excess return on allocated economic capital 8) Organic growth only; annual average growth (5 years), at unchanged f/x rates

Outlook

Revised Guidance for 2017

Hannover Re Group

Gross written premium1) more than 5%
Return on investment2) 3) more than 3.0%
Group net income2) ~
EUR 800 m.

Dividend payout unchanged on previous year's level (incl. special dividend)2)

1) At unchanged f/x rates

2) Subject to no major distortions in capital markets and/or major losses in Q4/2017 not exceeding the large loss budget of EUR 200 m.

3) Excluding effects from ModCo derivatives

Profitability 2017 below margin requirements Property & Casualty reinsurance: mixed picture by line of business

Volume1) Profitability2)
North America3) -
Continental Europe3) +
Marine +/-
Aviation -
Credit, surety and political risks +/-
UK, Ireland, London market and direct -
Facultative reinsurance +
Worldwide treaty3) reinsurance +/-
Cat XL -
Structured reinsurance and ILS +/-

1) In EUR, development in original currencies can be different

2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)

3) All lines of business except those stated separately

Good underlying profitability in L&H business

Reporting categories Volume1) Profitability2)
Financial
solutions
Financial solutions ++
Longevity +/-
Risk
solutions
Mortality -
Morbidity +/-

1) In EUR; development in original currencies can be different

2) ++ = well above CoC; + = above CoC; +/- = CoC earned; - = below Cost of Capital (CoC)

Guidance for 2018

Hannover Re Group

  • Gross written premium1) single-digit growth
  • Return on investment2) 3) 2.7%
  • Group net income2) more than EUR 1 bn.
  • Dividend payout ratio4) 35% 40% (If comfortable level of capitalisation remains unchanged, this ratio will increase through payment of another special dividend)

  • 2) Subject to no major distortions in capital markets and/or major losses in 2018 not exceeding the large loss budget of EUR 825 m.

  • 3) Excluding effects from ModCo derivatives
  • 4) Relative to group net income according to IFRS

1) At unchanged f/x rates

Rationale for our short- and medium-term outlook

Appendix

Our strategic business groups at a glance Q1-3/2017 vs. Q1-3/2016

Property & Casualty R/I Life & Health R/I Total
in m. EUR Q1-3/2016 Q1-3/2017 Δ Q1-3/2016 Q1-3/2017 Δ Q1-3/2016 Q1-3/2017 Δ
Gross written premium 7,121 8,199 +15.2% 5,333 5,284 -0.9% 12,454 13,484 +8.3%
Net premium earned 5,925 6,753 +14.0% 4,841 4,788 -1.1% 10,767 11,541 +7.2%
Net underwriting result 276 (309) - (231) (360) +55.8% 44 (669) -
Net underwriting result incl. funds withheld 294 (296) - 1 (193) - 294 (488) -
Net investment income 642 947 +47.4% 495 433 -12.5% 1,146 1,383 +20.6%
From assets under own management 624 933 +49.6% 263 266 +1.0% 897 1,202 +34.1%
From funds withheld 19 13 -27.9% 231 167 -27.9% 250 180 -27.9%
Other income and expenses (23) (36) 55.5% 26 133 - 0 92 -
Operating profit/loss (EBIT) 895 602 -32.8% 290 206 -29.1% 1,191 806 -32.3%
Interest on hybrid capital 0 0 +0.0% 0 0 - (54) (54) -0.0%
Net income before taxes 895 602 -32.8% 290 206 -29.1% 1,137 753 -33.8%
Taxes (244) (97) -60.4% (78) (66) -16.0% (307) (143) -53.4%
Net income 651 505 -22.4% 212 140 -33.9% 830 610 -26.6%
Non-controlling interest 35 56 +59.9% 3 5 +37.4% 38 61 +58.0%
Group net income 615 449 -27.1% 209 136 -35.0% 792 549 -30.7%
Retention 88.3% 89.2% 91.5% 91.5% 89.6% 90.1%
Combined ratio (incl. interest on funds withheld) 95.0% 104.4% 100.0% 104.0% 97.3% 104.2%
EBIT margin (EBIT / Net premium earned) 15.1% 8.9% 6.0% 4.3% 11.1% 7.0%
Tax ratio 27.3% 16.1% 26.9% 31.9% 27.0% 19.0%
Earnings per share (in EUR) 5.10 3.72 1.73 1.13 6.57 4.55

Our strategic business groups at a glance Q3/2017 vs. Q3/2016

Property & Casualty R/I Life & Health R/I Total
in m. EUR Q3/2016 Q3/2017 Δ Q3/2016 Q3/2017 Δ Q3/2016 Q3/2017 Δ
Gross written premium 2,493 2,772 +11.2% 1,677 1,714 +2.2% 4,170 4,486 +7.6%
Net premium earned 2,087 2,440 +16.9% 1,513 1,578 +4.3% 3,600 4,018 +11.6%
Net underwriting result 109 (458) - (62) (132) +113.3% 47 (590) -
Net underwriting result incl. funds withheld 116 (446) - 5 (86) - 121 (533) -
Net investment income 226 471 +108.1% 173 131 -24.1% 402 603 +50.2%
From assets under own management 219 460 +109.6% 105 86 -18.5% 327 546 +66.9%
From funds withheld 7 12 +63.7% 67 45 -32.8% 74 57 -23.6%
Other income and expenses (3) (46) - 0 41 - (5) (6) 32.3%
Operating profit/loss (EBIT) 332 (33) - 111 41 -63.4% 444 7 -98.4%
Interest on hybrid capital (0) 0 - (0) 0 - (18) (18) +0.3%
Net income before taxes 332 (33) - 111 41 -63.4% 426 (11) -102.6%
Taxes (86) 59 - (32) (19) -41.7% (112) 47 -
Net income 246 26 -89.3% 79 22 -72.2% 314 36 -88.6%
Non-controlling interest 9 22 +134.8% 1 1 -46.2% 10 22 +117.5%
Group net income 237 5 -98.0% 78 22 -72.5% 304 14 -95.4%
Retention 88.5% 88.8% 90.8% 91.2% 89.4% 89.7%
Combined ratio (incl. interest on funds withheld) 94.4% 118.3% 99.6% 105.5% 96.6% 113.3%
EBIT margin (EBIT / Net premium earned) 15.9% -1.3% 7.4% 2.6% 12.3% 0.2%
Tax ratio 25.8% 180.6% 28.8% 45.9% 26.3% -
Earnings per share (in EUR) 1.97 0.04 0.65 0.18 2.52 0.11

Barbell strategy still applied and visible in asset allocation Returns from liquidation of Listed Equity initially invested in government bonds

Asset allocation1)

Investment category 2013 2014 2015 2016 30 Sep 17
Fixed-income securities 90% 90% 87% 87% 88%
- Governments 19% 21% 26% 28% 31%
- Semi-governments 20% 19% 17% 18% 17%
- Corporates 36% 36% 34% 33% 32%
Investment grade 33% 33% 30% 28% 27%
Non-investment grade3
)
3% 3% 4% 4% 5%
- Pfandbriefe, Covered Bonds, ABS 15% 14% 10% 9% 2)
8%
Equities 2% 2% 3% 4% 2%
- Listed Equity <1% <1% 1% 2% < 1%
- Private Equity 2% 2% 2% 2% 2%
Real estate/real estate funds 4% 4% 4% 5% 5%
Others3
)
1% 1% 1% 1% 1%
Short-term investments & cash 4% 4% 5% 4% 5%
Total market values in bn. EUR 32.2 36.8 39.8 42.3 40.6

1) Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments

of EUR 1,053.7 m. (EUR 1,036.8 m.) as at 30 September 2017

2) Of which Pfandbriefe and Covered Bonds = 75.5%

3) Reallocation of High Yield Funds from "Others" to "Corporates – Non-investment grade"

Stress tests on assets under own management

Unchanged focus on yields and spreads; reduced relevance of Equity investments

Portfolio Scenario Change in market value
in m. EUR
Change in OCI before tax
in m. EUR
-10% -88 -88
Equity (listed and private equity) -20% -176 -176
+50 bps -869 -784
Fixed-income securities +100 bps -1,692 -1,527
Credit spreads +50% -717 -691

As at 30 September 2017

Fixed-income book well balanced Geographical allocation mainly in accordance with our business diversification

</bbb<>
Governments Semi
governments
Corporates Pfandbriefe,
Covered bonds,
ABS
Short-term
investments,
cash
Total
AAA 78.0% 66.7% 1.1% 65.8% - 47.5%
A
A
11.5% 22.8% 12.4% 12.4% - 14.1%
A 5.4% 5.3% 33.1% 7.1% - 15.4%
BBB 3.6% 1.3% 44.1% 10.8% - 18.1%
<bbb< td="">1.5%3.9%9.3%3.8%-4.9% 1.5% 3.9% 9.3% 3.8% - 4.9%
Total 100.0% 100.0% 100.0% 100.0% - 100.0%
Germany 13.7% 50.0% 4.1% 25.0% 34.5% 19.2%
UK 7.1% 2.5% 8.3% 9.9% 6.4% 6.9%
France 1.4% 1.9% 8.0% 5.6% 0.6% 4.0%
GIIPS 1.1% 1.0% 4.7% 4.6% 0.0% 2.6%
Rest of Europe 3.6% 13.9% 16.9% 24.3% 5.0% 11.8%
USA 58.3% 4.0% 34.9% 6.4% 12.1% 33.6%
Australia 3.9% 8.8% 7.4% 11.8% 6.8% 6.8%
Asia 6.4% 5.8% 5.1% 0.2% 20.6% 6.0%
Rest of World 4.5% 12.1% 10.5% 12.2% 14.0% 9.1%
Total 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Total b/s values in m. EUR 12,431 6,712 12,195 3,180 1,829 36,347

IFRS figures as at 30 September 2017

Currency allocation matches liability profile of balance sheet Duration-neutral strategy applied

Currency split of investments

  • Modified duration of fixedincome mainly congruent with liabilities
  • GBP's higher modified duration predominantly due to life business

Modified duration

2016 5.0
2015 4.4
2014 4.6
2013 4.4
2012 4.5

Modified duration as at 30 September 2017: 4.9

Solvency II ratio (regulatory view) Hannover Re Group

Development of the Solvency II ratio (regulatory view)

VII Conference Call on Interim Report 3/2017

Disclaimer

This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities.

While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-to-date, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.

Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements.

This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re.

© Hannover Rück SE. All rights reserved.

Hannover Re is the registered service mark of Hannover Rück SE.

Talk to a Data Expert

Have a question? We'll get back to you promptly.